Tengion's platform technologies are applicable to the development of a variety of innovative product candidates for the treatment of organ and tissue impairment, failure and loss in the genitourinary and other systems. Tengion is developing additional autologous neo-organs and tissues that harness the body's ability to regenerate.
Based upon the principles demonstrated with Tengion Neo-Bladder Augment™, Tengion is developing Tengion Neo-Kidney Augment™ product candidates.
Tengion Neo-Kidney Augment is being developed with the goal of using a patient's own cells to augment or replace renal function for patients with chronic renal failure who are dependent on dialysis treatment and for patients who receive medical treatment for chronic anemia.
The Tengion Neo-Kidney Augment program is not yet in clinical development and is not commercially available.